Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ENDRA Life Sciences (NDRA) Other Working Capital Changes: 2016-2021

Historic Other Working Capital Changes for ENDRA Life Sciences (NDRA) over the last 5 years, with Dec 2021 value amounting to $1.7 million.

  • ENDRA Life Sciences' Other Working Capital Changes rose 142.55% to $1.7 million in Q4 2021 from the same period last year, while for Dec 2021 it was $957,203, marking a year-over-year increase of 249.28%. This contributed to the annual value of -$255,913 for FY2024, which is 52.91% down from last year.
  • As of Q4 2021, ENDRA Life Sciences' Other Working Capital Changes stood at $1.7 million, which was up 937.15% from -$208,278 recorded in Q3 2021.
  • ENDRA Life Sciences' 5-year Other Working Capital Changes high stood at $1.7 million for Q4 2021, and its period low was -$1.2 million during Q2 2020.
  • Moreover, its 3-year median value for Other Working Capital Changes was $76,140 (2019), whereas its average is $111,491.
  • Its Other Working Capital Changes has fluctuated over the past 5 years, first slumped by 16,486.79% in 2017, then skyrocketed by 9,613.38% in 2020.
  • Over the past 5 years, ENDRA Life Sciences' Other Working Capital Changes (Quarterly) stood at -$33,757 in 2017, then soared by 95.60% to -$1,484 in 2018, then soared by 1,014.22% to $13,567 in 2019, then surged by 5,198.56% to $718,856 in 2020, then soared by 142.55% to $1.7 million in 2021.
  • Its Other Working Capital Changes was $1.7 million in Q4 2021, compared to -$208,278 in Q3 2021 and -$963,415 in Q2 2021.